Genesis Healthcare Partners PC
Genesis Healthcare Partners PC was paid $12.51M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoGENESIS HEALTHCARE PARTNERS PC
SAN DIEGO, CA 92123
SAN DIEGO, CA 92123
33aNPI1548567498assigned 02/11/2011
33bProvider typeSpecialist
28Total paid$12.51M
24GClaims229,492
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#13 of 1,230
Median peer was paid$51K
This provider vs. median244×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,676 | $997K | |
| 2019 | 25,005 | $1.45M | |
| 2020 | 19,229 | $951K | |
| 2021 | 26,469 | $1.49M | |
| 2022 | 35,438 | $2.17M | |
| 2023 | 54,520 | $3.14M | |
| 2024incomplete | 49,155 | $2.31M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 30,046 | 28,879 | $2.38M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 18% | 17,457 | 17,390 | $2.23M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 29,627 | 28,809 | $1.85M |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 8.5% | 3,723 | 948 | $1.06M |
| 52000 | 7.7% | 5,228 | 5,189 | $959K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.1% | 6,947 | 6,923 | $636K |
| 51798 | 2.4% | 21,194 | 20,285 | $305K | |
| 77014 | 2.4% | 3,759 | 963 | $305K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.5% | 2,711 | 2,668 | $181K |
| 99439 | 1.4% | 4,092 | 4,087 | $175K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 1.4% | 538 | 530 | $173K |
| 99490 | Ccm add 20min | 1.3% | 5,930 | 5,911 | $168K |
70 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 2,980 | $157K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 3,672 | $155K |
| 51728 | 1.2% | 749 | $150K | |
| 52442 | 1.2% | 46 | $145K | |
| 76872 | 1.1% | 1,184 | $140K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,312 | $122K |
| 81003 | <1% | 41,125 | $120K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 1,069 | $113K |
| 88312 | <1% | 1,527 | $96K | |
| 99223 | Prolong inpt eval add15 m | <1% | 668 | $69K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 989 | $61K |
| 88313 | <1% | 1,578 | $60K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 679 | $57K |
| 52441 | <1% | 43 | $54K | |
| 81002 | <1% | 19,750 | $48K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,198 | $45K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 391 | $45K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 319 | $41K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,934 | $41K |
| 51784 | <1% | 1,030 | $38K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 2,688 | $36K |
| J0897 | Injection, denosumab, 1 mg | <1% | 36 | $29K |
| 51705 | <1% | 406 | $26K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 329 | $23K |
| 51701 | <1% | 462 | $21K | |
| 77336 | <1% | 405 | $18K | |
| 96402 | <1% | 919 | $18K | |
| 77427 | <1% | 181 | $17K | |
| 51700 | <1% | 240 | $16K | |
| 51729 | <1% | 46 | $14K | |
| 51741 | <1% | 1,164 | $11K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,974 | $11K |
| 99205 | Prolong outpt/office vis | <1% | 60 | $11K |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | <1% | 383 | $10K |
| 64566 | <1% | 75 | $10K | |
| 99454 | <1% | 183 | $8K | |
| 76770 | <1% | 109 | $6K | |
| 46221 | <1% | 42 | $6K | |
| 52356 | <1% | 13 | $6K | |
| 51797 | <1% | 30 | $5K | |
| 52310 | <1% | 12 | $4K | |
| 00811 | <1% | 24 | $4K | |
| 88112 | <1% | 232 | $4K | |
| 99457 | <1% | 104 | $4K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 142 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 167 | $3K |
| 55700 | <1% | 13 | $2K | |
| 81000 | <1% | 455 | $1K | |
| 43235 | <1% | 13 | $1K | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 140 | $901.66 |
| 99442 | <1% | 12 | $753.47 | |
| 88360 | <1% | 26 | $294.79 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | <1% | 13 | $275.57 |
| 82570 | <1% | 504 | $256.48 | |
| 88121 | <1% | 12 | $243.96 | |
| 81001 | <1% | 524 | $180.35 | |
| 87799 | <1% | 28 | $128.52 | |
| 87492 | <1% | 21 | $53.47 | |
| 87592 | <1% | 21 | $42.84 | |
| 87652 | <1% | 21 | $41.76 | |
| 87512 | <1% | 21 | $41.76 | |
| 87481 | <1% | 21 | $35.09 | |
| 87641 | <1% | 22 | $35.09 | |
| 87653 | <1% | 21 | $35.09 | |
| 87640 | <1% | 21 | $35.09 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 21 | $35.09 |
| 87500 | <1% | 22 | $35.09 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 195 | $10.00 |
| 1036F | 0% | 1,359 | $0.00 | |
| 1126F | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOHEN, EDWARD (CEO AND BOARD CHAIR)